Compare LAKE & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAKE | XTNT |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.1M | 68.9M |
| IPO Year | 2013 | 2009 |
| Metric | LAKE | XTNT |
|---|---|---|
| Price | $9.08 | $0.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.33 | $1.00 |
| AVG Volume (30 Days) | 79.3K | ★ 171.5K |
| Earning Date | 04-16-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $167,211,000.00 | $53,337,000.00 |
| Revenue This Year | $19.75 | N/A |
| Revenue Next Year | $6.94 | $9.15 |
| P/E Ratio | ★ N/A | $15.20 |
| Revenue Growth | ★ 2554.14 | N/A |
| 52 Week Low | $7.15 | $0.34 |
| 52 Week High | $20.50 | $0.95 |
| Indicator | LAKE | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 24.14 |
| Support Level | $8.70 | N/A |
| Resistance Level | $9.67 | $0.68 |
| Average True Range (ATR) | 0.44 | 0.04 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 99.49 | 4.71 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.